Skip to main content
. 2018 Jan 8;50(4):1324–1330. doi: 10.4143/crt.2017.526

Fig. 2.

Fig. 2.

Survival outcomes with oxaliplatin, irinotecan, and S-1 combination treatment. CI, confidence interval.